Deficient in vitro megakaryocytopoiesis and decreased in vivo platelet turnover in children and young adults with chronic thrombocytopenia

Journal of Pediatric Hematology/Oncology

Volumn 20, Issue 3, 1998, Pages 196-201

  Parker, Robert I ^a,d   Siegel, Robert S ^b   Ratajczak, Mariusz Z ^c   Gewirtz, Alan M ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d STONY BROOK UNIVERSITY   (United States)

Author keywords

ITP; Megakaryocyte growth; Myelodysplasia; Platelet turnover

Indexed keywords

IMMUNOGLOBULIN G;

ARTICLE; BONE MARROW CELL; CELL SURVIVAL; COLONY FORMATION; HUMAN; HUMAN CELL; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOMODULATION; KARYOTYPE; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MYELODYSPLASIA; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; THROMBOCYTE FUNCTION; THROMBOCYTE METABOLISM;

ADOLESCENT; ADULT; BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; COLONY-FORMING UNITS ASSAY; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELLS; HUMANS; INDIUM RADIOISOTOPES; INFANT; INFANT, NEWBORN; KARYOTYPING; MALE; MEGAKARYOCYTES; THROMBOCYTOPENIA;

EID: 0031867827     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199805000-00003     Document Type: Article

References (21)

1. 51Cr-labeled platelets differ. Blood 1986;67:86-92.
2. Gernsheimer T, Stratton J, Ballem PJ, et al. Mechanisms of response to treatment in autoimmune thrombocytopenic purpura. N Engl J Med 1989;320:974-80.
3. Siegel RS, Rae JL, Barth S, et al. Platelet survival and turnover: important factors in predicting response to splenectomy in immune thrombocytopenic purpura. Am J Hematol 1990;30:206-12.
4. Isaka Y, Kambayashi J, Kumura K, et al. Platelet production, clearance and distribution in patients with idiopathic thrombocytopenic purpura. Thromb Res 1990;60:121-31.
5. Ballem PJ, Segal GM, Stratton JR, et al. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. J Clin Invest 1987;80:33-40.
6. McMillan R, Luikens GA, Levy R, et al. Antibody against megakaryocytes in idiopathic thrombocytopenic purpura. JAMA 1978;239:2460-2.
7. Parker RI, Rick ME, Gralnick HR. A method to minimize platelet activation during platelet isolation. Thromb Res 1984;36:265-70.
8. Heaton WA, Davis HH, Welch MJ, et al. Indium-111: A new radionuclide label for studying human platelet kinetics. Br J Haematol 1979;42:613-22.
9. ICSH Panel on Diagnostic Application of Radioisotopes in Hematology. Recommended methods for radioisotope platelet survival studies. Blood 1977;50:1137-44.
10. Murphy EA, Frances ME. The estimation of blood platelet survival II. The multiple hit model. Thrombosis Diathesis Haemorrhagia 1971;25:53-80.
11. Gewirtz AM, Bruno E, Elwell J, et al. In vitro studies of megakaryocytopoiesis in thrombocytotic disorders of man. Blood 1983;61:384-9.
12. Gewirtz AM, Calabretta B, Rucinski B, et al. Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. J Clin Invest 1989;83:1477-86.
13. Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 1985;66:1105-9.
14. Nishi N, Nakahata T, Koike K, et al. Induction of mixed erythroid-megakaryocytic colonies and bipotential blast cell colonies by recombinant human erythropoietin in serum-free culture. Blood 1990;76:1330-5.
15. Kobayashi M, Laver JH, Kato T, et al. Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors. Blood 1995;86:2494-9.
16. Debili N, Coulombel L, Croiselle L, et al. Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood 1996;88:1284-96.
17. Bessman JD, Williams LJ, Gilmer PR Jr. Platelet size in health and hematologic disease. Am J Clin Pathol 1982;78:150-3.
18. Garg SK, Amarosi EL, Karpatkin S. Use of the megathrombocyte as an index of megakaryocyte number. N Engl J Med 1971;284:11-7.
19. Hegde UM. Platelet antibodies in immune thrombocytopenia. Blood Rev 1992;6:34-42.
20. Steinberg MH, Kelton JG, Coller BS. Plasma glycocalicin: An aid in the classification of thrombocytopenic disorders. N Engl J Med 1987;317:1037-412.
21. Beer JH, Buchi L, Steiner B. Glycocalicin: a new assay - the normal plasma level and its potential usefulness in selected diseases. Blood 1994;83:691-702.